Search research articles
Contact Us
Filters
Showing results (1-10 of 140) with videos related to
Page
of 14
Sort By:
Current Diabetes Reports
|
July 31, 2012
Autologous regulatory T cells for the treatment of type 1 diabetes
James A Thompson, Daniel Perry, Todd M Brusko
Immunological Reviews
|
July 11, 2008
Human regulatory T cells: role in autoimmune disease and therapeutic opportunities
Todd M Brusko, Amy L Putnam, Jeffrey A Bluestone
Science (New York, N.Y.)
|
July 30, 2021
Strategies for durable β cell replacement in type 1 diabetes
Todd M Brusko, Holger A Russ, Cherie L Stabler
Current Opinion in Endocrinology, Diabetes, and Obesity
|
May 31, 2019
Pleiotropic roles of the insulin-like growth factor axis in type 1 diabetes
Melanie R Shapiro, Mark A Atkinson, Todd M Brusko
Frontiers in Endocrinology
|
November 3, 2017
Isogenic Cellular Systems Model the Impact of Genetic Risk Variants in the Pathogenesis of Type 1 Diabetes
Mark A Wallet, Katherine E Santostefano, Naohiro Terada, et al.
Immunotherapy
|
November 29, 2013
Influence of host immunoregulatory genes, ER stress and gut microbiota on the shared pathogenesis of inflammatory bowel disease and Type 1 diabetes
Altin Gjymishka, Roxana M Coman, Todd M Brusko, et al.
Diabetes
|
December 22, 2011
Central role for interleukin-2 in type 1 diabetes
Maigan A Hulme, Clive H Wasserfall, Mark A Atkinson, et al.
International Journal of Molecular Sciences
|
August 8, 2018
Myeloid-Derived Suppressor Cells and Pulmonary Hypertension
Andrew J Bryant, Borna Mehrad, Todd M Brusko, et al.
Current Diabetes Reports
|
October 13, 2017
T Cell Receptor Profiling in Type 1 Diabetes
Laura M Jacobsen, Amanda Posgai, Howard R Seay, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 22, 2005
An integral role for heme oxygenase-1 and carbon monoxide in maintaining peripheral tolerance by CD4+CD25+ regulatory T cells
Todd M Brusko, Clive H Wasserfall, Anupam Agarwal, et al.
Page
of 14
Search research articles
Search
Showing results (1-10 of 140) with videos related to
Sort By:
Page
of 14
Current Diabetes Reports
|
July 31, 2012
Autologous regulatory T cells for the treatment of type 1 diabetes
James A Thompson, Daniel Perry, Todd M Brusko
Immunological Reviews
|
July 11, 2008
Human regulatory T cells: role in autoimmune disease and therapeutic opportunities
Todd M Brusko, Amy L Putnam, Jeffrey A Bluestone
Science (New York, N.Y.)
|
July 30, 2021
Strategies for durable β cell replacement in type 1 diabetes
Todd M Brusko, Holger A Russ, Cherie L Stabler
Current Opinion in Endocrinology, Diabetes, and Obesity
|
May 31, 2019
Pleiotropic roles of the insulin-like growth factor axis in type 1 diabetes
Melanie R Shapiro, Mark A Atkinson, Todd M Brusko
Frontiers in Endocrinology
|
November 3, 2017
Isogenic Cellular Systems Model the Impact of Genetic Risk Variants in the Pathogenesis of Type 1 Diabetes
Mark A Wallet, Katherine E Santostefano, Naohiro Terada, et al.
Immunotherapy
|
November 29, 2013
Influence of host immunoregulatory genes, ER stress and gut microbiota on the shared pathogenesis of inflammatory bowel disease and Type 1 diabetes
Altin Gjymishka, Roxana M Coman, Todd M Brusko, et al.
Diabetes
|
December 22, 2011
Central role for interleukin-2 in type 1 diabetes
Maigan A Hulme, Clive H Wasserfall, Mark A Atkinson, et al.
International Journal of Molecular Sciences
|
August 8, 2018
Myeloid-Derived Suppressor Cells and Pulmonary Hypertension
Andrew J Bryant, Borna Mehrad, Todd M Brusko, et al.
Current Diabetes Reports
|
October 13, 2017
T Cell Receptor Profiling in Type 1 Diabetes
Laura M Jacobsen, Amanda Posgai, Howard R Seay, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 22, 2005
An integral role for heme oxygenase-1 and carbon monoxide in maintaining peripheral tolerance by CD4+CD25+ regulatory T cells
Todd M Brusko, Clive H Wasserfall, Anupam Agarwal, et al.
Page
of 14